India's Glenmark Life Sciences slides as Q4 profit falls

Alivus Life Sciences

25/04/2024 10:39

** Shares of Glenmark Life Sciences  GLEM.NS  fall as much
as 8.8% to 753.55 rupees
    ** The active pharmaceutical ingredients maker's
fourth-quarter profit fell over 33% y/y to 979.4 mln rupees
($11.8 mln), rev from ops down 13.5% 
    ** Stock was little changed ahead of the results
    ** Including session's move, stock up ~15% YTD 



($1 = 83.3230 Indian rupees)

 (Reporting by Manvi Pant in Bengaluru)
 ((Manvi.Pant@thomsonreuters.com; +918447554364;))